Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010309
Status:
UNKNOWN
Last Update Posted:
2014-01-06
First Post:
2001-02-02
Brief Title:
Vaccine Therapy in Treating Patients Who Have Stage II Stage III or Stage IV Melanoma
Sponsor:
Genzyme a Sanofi Company
Organization:
National Cancer Institute NCI